Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19.

MLA

Takita, Mumon, et al. “Low SARS-CoV-2 Antibody Titers May Be Associated with Poor Clinical Outcomes for Patients with Severe COVID-19.” Scientific Reports, vol. 12, no. 1, June 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-022-12834-w.

APA

Takita, M., Yoshida, T., Tsuchida, T., Nakagama, Y., Kido, Y., Suzuki, S., Imamura, M., Kawahata, K., Shimizu, G., Yoshida, H., Morikawa, D., Kawaguchi, T., Fujii, S., Tsukuda, J., Motohashi, T., & Fujitani, S. (2022). Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19. Scientific Reports, 12(1), 1–11. https://doi.org/10.1038/s41598-022-12834-w

Chicago

Takita, Mumon, Toru Yoshida, Tomoya Tsuchida, Yu Nakagama, Yasutoshi Kido, Shotaro Suzuki, Mitsuru Imamura, et al. 2022. “Low SARS-CoV-2 Antibody Titers May Be Associated with Poor Clinical Outcomes for Patients with Severe COVID-19.” Scientific Reports 12 (1): 1–11. doi:10.1038/s41598-022-12834-w.